Globus Medical (GMED) Gross Margin (2011 - 2026)

Globus Medical has reported Gross Margin for 16 years, with the latest figure at 69.2% in Q1 2026.

• For the quarter ending Q1 2026, Gross Margin rose 186.0% year-over-year to 69.2%; the trailing twelve-month figure through Mar 2026 stood at 67.86% (up 727.0% YoY), and the FY2025 full-year result was 67.41%, up 851.0% from the prior year.
• Gross Margin for Q1 2026 stood at 69.2%, up from 68.41% in the prior quarter.
• The five-year high for Gross Margin was 74.4% in Q1 2023, with the low at 56.77% in Q3 2024.
• Historically, Gross Margin has averaged 67.12% across 5 years, with a median of 67.33% in 2025.
• Annual changes were most pronounced in 2023 — Gross Margin slumped 1734 bps — and 2025, when it surged 1040 bps.
• Globus Medical's Gross Margin stood at 74.28% in 2022, then decreased by 23 bps to 56.94% in 2023, then increased by 5 bps to 59.92% in 2024, then gained by 14 bps to 68.41% in 2025, then grew by 1 bps to 69.2% in 2026.
• The last three Gross Margin figures came in at 69.2% (Q1 2026), 68.41% (Q4 2025), and 67.16% (Q3 2025), per Business Quant data.